InhaLac® 140
Premium milled DPI alpha-lactose monohydrate – Ph. Eur., USP-NF, JP, ChP
Milled DPI lactose, with its fine particle size and increased surface area, improves drug adhesion and detachment, optimizing the delivery of active ingredients to the lower respiratory tract.
InhaLac® 140 is a milled lactose monohydrate with a median particle size (x50) of ~159 µm, engineered for DPI formulations requiring optimized flow and blending properties. Its controlled PSD supports uniform drug dispersion.
Benefits
- Highly controlled and homogenous powder characteristics
- Highest microbial quality including low endotoxins
- Retest after 24 months
Areas of Application
- InhaLac® 140 as middle-sized milled carier lactose is suitable for use in pulmonary and nasal drug delivery.
Order your free sample!
- Dry Powder Inhalation
- Inhalation Lactose
- Milled Lactose DPI
- Inhalation
- Nasal
- Dry Powder Inhaler (DPI)
- Capsule Device (DPI)
- Blister Device (DPI)
25kg – Carton box with aluminium laminated and PE-EVOH-PE inliner
24 months
Wasserburg am Inn, Germany
Downloads
Typical particle size distribution
Typical Product Data
- x10: 5.6 µm, x50: 45 µm, x90: 135 µm
- Span [(x90-x10)/x50]: 2.9
- % fines <5 µm: 10
- Density bulk: 0.58 g/ml
- Density tapped: 0.90 g/ml
- Hausner Ratio: 1.55
- Carr’s Index: 35 %
Specified Product Data
Particle size distribution
Sieve Method: Laser diffraction
- x10: 3 – 7 µm
- x50: 37 – 61 µm
- x90: 120 – 190 µm
Do you have any questions or need a customised solution?